nimotuzumab
biocon,daiichi sankyo,oncoscience
['improve', 'nimotuzumab', 'pancsm']
dr shukui qin presents antiegfr antibody nimotuzumab with gemcitabine for kras wt #pancsm after a favorable ph2 trial showing potential for improved survival #gionc #asco22 
#FosterCare alum, #GIonc, #pallonc, and #survonc doc @ParkviewHealth.Uniting support and cancer care #supponc #hpm #hapc  Tweets are own.